DK1553832T3 - Præparater og fremgangsmåder til celleseparering - Google Patents

Præparater og fremgangsmåder til celleseparering

Info

Publication number
DK1553832T3
DK1553832T3 DK03759533T DK03759533T DK1553832T3 DK 1553832 T3 DK1553832 T3 DK 1553832T3 DK 03759533 T DK03759533 T DK 03759533T DK 03759533 T DK03759533 T DK 03759533T DK 1553832 T3 DK1553832 T3 DK 1553832T3
Authority
DK
Denmark
Prior art keywords
methods
cell separation
preparations
separation preparations
reagents
Prior art date
Application number
DK03759533T
Other languages
English (en)
Inventor
Daniel P Collins
Joel H Hapke
Carol A Buchert
Original Assignee
Bioe Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioe Inc filed Critical Bioe Inc
Application granted granted Critical
Publication of DK1553832T3 publication Critical patent/DK1553832T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0093—Purging against cancer cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK03759533T 2002-09-27 2003-09-26 Præparater og fremgangsmåder til celleseparering DK1553832T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41469202P 2002-09-27 2002-09-27
PCT/US2003/030265 WO2004029208A2 (en) 2002-09-27 2003-09-26 Cell separation compositions and methods

Publications (1)

Publication Number Publication Date
DK1553832T3 true DK1553832T3 (da) 2007-10-01

Family

ID=32043402

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03759533T DK1553832T3 (da) 2002-09-27 2003-09-26 Præparater og fremgangsmåder til celleseparering

Country Status (13)

Country Link
US (1) US6933148B2 (da)
EP (1) EP1553832B1 (da)
JP (1) JP4344696B2 (da)
CN (1) CN100350040C (da)
AT (1) ATE366801T1 (da)
AU (1) AU2003275260B2 (da)
CA (1) CA2499826C (da)
DE (1) DE60314898T2 (da)
DK (1) DK1553832T3 (da)
IL (1) IL167624A (da)
MX (1) MXPA05003260A (da)
RU (1) RU2346039C2 (da)
WO (1) WO2004029208A2 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL158171A0 (en) * 2001-04-10 2004-03-28 Bioergonomics Inc Compositions and methods for cell separation
US8603345B2 (en) * 2003-02-13 2013-12-10 Becton, Dickinson And Company Devices for component removal during blood collection, and uses thereof
US7622108B2 (en) 2004-04-23 2009-11-24 Bioe, Inc. Multi-lineage progenitor cells
US7670596B2 (en) 2004-04-23 2010-03-02 Bioe, Inc. Multi-lineage progenitor cells
WO2007092028A2 (en) * 2005-04-08 2007-08-16 Medical Discovery Partners Llc Method for enriching rare cell subpopulations from blood
US7875453B2 (en) * 2006-06-14 2011-01-25 Bioe Llc Differentiation of multi-lineage progenitor cells to hepatocytes
RU2495882C2 (ru) 2006-09-08 2013-10-20 Медиммун, Ллк. Гуманизированные антитела к cd19 и их применение для лечения онкологического, связанного с трансплантацией и аутоиммунного заболевания
US7713688B2 (en) * 2007-01-26 2010-05-11 Bioe, Llc Methods and compositions for depleting specific cell populations from blood tissues
WO2009149382A2 (en) * 2008-06-06 2009-12-10 Baylor Research Institute Anti-cd8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory cd8+t cells
CN104588140B (zh) 2008-07-21 2016-06-29 贝克顿·迪金森公司 密度相分离装置
CN102149472B (zh) 2008-07-21 2014-08-13 贝克顿·迪金森公司 密度相分离装置
CA2731156C (en) 2008-07-21 2013-09-24 Becton, Dickinson And Company Density phase separation device
CN101403749B (zh) * 2008-11-17 2012-11-07 北京大学 通过葡聚糖特异性抗体辅助诊断自身免疫性疾病的试剂盒
PL3006109T3 (pl) 2009-05-15 2019-12-31 Becton, Dickinson And Company Urządzenie do rozdzielania faz gęstości
DK3159001T3 (da) * 2009-09-15 2019-06-17 Univ Tokyo Hidtil ukendt fremgangsmåde til fremstilling af differentierede celler
WO2012061291A2 (en) * 2010-11-01 2012-05-10 Bioe Llc Methods and compositions for cell separation of blood tissues
EP2643694B1 (en) * 2010-11-24 2018-01-03 Litron Laboratories Ltd. Rapid in vivo gene mutation assay based on the pig-a gene
EP2681555B1 (en) 2011-02-25 2020-04-08 Benaroya Research Institute Detection of an allergic disorder
CN102839152A (zh) * 2011-06-20 2012-12-26 中国科学院上海生命科学研究院 一种快速高效获得抗原特异性b细胞的方法
ES2602500T3 (es) * 2011-11-25 2017-02-21 Miltenyi Biotec Gmbh Método de separación celular
US20140295542A1 (en) * 2013-04-01 2014-10-02 Bhc Technology Holdings Llc Cell separation compositions and methods for separating and recovering therapeutic cells in blood tissue
US9694359B2 (en) 2014-11-13 2017-07-04 Becton, Dickinson And Company Mechanical separator for a biological fluid
CN108586612A (zh) * 2018-03-27 2018-09-28 深圳联合医学科技有限公司 一种适用于检测人外周血表达cd161分子亚群淋巴细胞的单克隆抗体的制备方法
RU2020122145A (ru) * 2020-07-03 2022-01-04 Петр Иванович Никитин Композиция и способ для улучшения эффективности или снижения побочных эффектов терапевтического агента, используемого для доставки нуклеиновых кислот
CN118388650B (zh) * 2024-06-28 2024-08-27 杭州赛基生物科技有限公司 一种抗CD235a单克隆抗体及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5840502A (en) * 1994-08-31 1998-11-24 Activated Cell Therapy, Inc. Methods for enriching specific cell-types by density gradient centrifugation
US6117985A (en) * 1995-06-16 2000-09-12 Stemcell Technologies Inc. Antibody compositions for preparing enriched cell preparations
US5877299A (en) * 1995-06-16 1999-03-02 Stemcell Technologies Inc. Methods for preparing enriched human hematopoietic cell preparations
US6146628A (en) * 1995-07-11 2000-11-14 Regents Of The University Of Minnesota And Rutgers Biotherapeutic agents comprising recombinant PAP and PAP mutants
CA2279474C (en) * 1998-07-31 2011-01-04 Stemcell Technologies Inc. Novel antibody composition for debulking blood and bone marrow samples from cml patients
US6153113A (en) * 1999-02-22 2000-11-28 Cobe Laboratories, Inc. Method for using ligands in particle separation
CA2375115C (en) * 1999-05-28 2011-05-24 Stemcell Technologies Inc. Method for separating cells using immunorosettes
IL158171A0 (en) * 2001-04-10 2004-03-28 Bioergonomics Inc Compositions and methods for cell separation

Also Published As

Publication number Publication date
DE60314898D1 (de) 2007-08-23
AU2003275260A1 (en) 2004-04-19
US20040062766A1 (en) 2004-04-01
WO2004029208A2 (en) 2004-04-08
DE60314898T2 (de) 2008-03-13
AU2003275260B2 (en) 2008-01-24
WO2004029208A3 (en) 2005-04-14
EP1553832A4 (en) 2006-02-01
JP2006500932A (ja) 2006-01-12
CN100350040C (zh) 2007-11-21
MXPA05003260A (es) 2005-09-12
EP1553832A2 (en) 2005-07-20
IL167624A (en) 2009-12-24
RU2346039C2 (ru) 2009-02-10
US6933148B2 (en) 2005-08-23
CN1735346A (zh) 2006-02-15
RU2005112731A (ru) 2006-01-20
ATE366801T1 (de) 2007-08-15
EP1553832B1 (en) 2007-07-11
CA2499826A1 (en) 2004-04-08
JP4344696B2 (ja) 2009-10-14
CA2499826C (en) 2015-03-24

Similar Documents

Publication Publication Date Title
DK1553832T3 (da) Præparater og fremgangsmåder til celleseparering
DE60238801D1 (de) Zelltrennungszusammensetzungen und -verfahren
WO2007067782A3 (en) Compositions and methods for inducing the activation of immature monocytic dendritic cells
ATE536187T1 (de) Hla-klasse-i- und -klasse-ii-bindende peptide und ihre verwendungen
DE69802191D1 (de) Festphase nukleinsäure-isolierung
CY1111098T1 (el) Bodipy διαιθυλοακεταλη αμινοακεταλδεϋδης
ATE512666T1 (de) Hla-bindende peptide und ihre verwendungen
SG170065A1 (en) Human embryonic stem cell methods and podxl expression
ATE519536T1 (de) Methode zum trennen von zellen
WO2004111075A3 (en) Alternative reading frame polypeptides for treatment
NO20052363L (no) Interferon-alfa polypeptider og konjugater
WO2004055491A3 (en) Novel method for sequence determination using nmr
EP2117592A4 (en) METHOD AND COMPOSITION FOR REMOVING SPECIFIC CELL POPULATIONS FROM BLOOD TISSUE
WO2002082083A1 (en) Electrophoresis
DK1321477T3 (da) Fremgangsmåde til frembringelsen af genetisk modificerede vertebrate precursor-lymfocytter og anvendelse deraf til fremstillingen af heterologe bindende proteiner
WO2007127659A3 (en) Methods and compositions for separating cells
AU7963901A (en) Method for electrophoretically separating membrane proteins
DK1576157T3 (da) Fluorescerende proteiner fra Copepode-arter og fremgangsmåder til anvendelse af samme
ATE483724T1 (de) Verfahren zur erhöhung der ausbreitung von b- zellen
ZA200610470B (en) Novel sequence for improving expression of nucleic acid
DK1723233T3 (da) Fremgangsmåde til berigelse og/eller adskillelse prokaryotisk DNA ved hjælp af et protein, som specifikt binder DNA indeholdende ikke-methylerede CPG-motiver
ES2421558T3 (es) Anticuerpos específicos de cáncer y proteínas de superficie celular
WO2004072262A3 (en) Cultured cd14+ antigen presenting cells
WO2004067750A3 (en) Xenorhabdus tc proteins and genes for pest control
WO2004016803A3 (en) Method of enhancing cd4+ t cell responses